Received Feb 13, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
Infanrix - Administration to an adult patient.; Infanrix - Administration to an adult patient.; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of wrong vaccine administered in a 67-year-old female patient who received DTPa (Infanrix) for prophylaxis. Co-suspect products included Tetanus vaccine for prophylaxis. On 31-JAN-2026, the patient received Infanrix. On an unknown date, the patient received Tetanus vaccine. On 31-JAN-2026, an unknown time after receiving Infanrix and an unknown time after receiving Tetanus vaccine, the patient experienced wrong vaccine administered (Verbatim: Infanrix - Administration to an adult patient.) and inappropriate age at vaccine administration (Verbatim: Infanrix - Administration to an adult patient.). The outcome of the wrong vaccine administered and inappropriate age at vaccine administration were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date 06-FEB-2026 A pharmacist called to ask for recommendations regarding the administration of Infanrix. The patient was supposed to receive a tetanus booster, but Infanrix was administered instead. No further details provided. The reporter consented to follow up. The batch number was not provided upon follow- up with the reporter.